Advances in vaccine adjuvants - PubMed (original) (raw)
Review
. 1999 Nov;17(11):1075-81.
doi: 10.1038/15058.
Affiliations
- PMID: 10545912
- DOI: 10.1038/15058
Review
Advances in vaccine adjuvants
M Singh et al. Nat Biotechnol. 1999 Nov.
Abstract
Currently, aluminum salts and MF59 are the only vaccine adjuvants approved for human use. With the development of new-generation vaccines (including recombinant subunit and mucosal vaccines) that are less immunogenic, the search for more potent vaccine adjuvants has intensified. Of the novel compounds recently evaluated in human trials, immunostimulatory molecules such as the lipopolysaccharide derived MPL and the saponin derivative QS21 appear most promising, although doubts have been raised as to their safety in humans. Preclinical work with particulate adjuvants, such as the MF59 microemulsion and lipid-particle immune-stimulating complexes (Iscoms), suggest that these molecules are also potent elicitors of humoral and cellular immune responses. In addition, preclinical data on CpG oligonucleotides appear to be encouraging, particularly with respect to their ability to selectively manipulate immune responses. While all these adjuvants show promise, further work is needed to better define the mechanisms of adjuvant action. Ultimately, the development of more potent adjuvants may allow vaccines to be used as therapeutic, rather than prophylactic, agents.
Similar articles
- [Adjuvants--essential components of new generation vaccines].
Dzierzbicka K, Kołodziejczyk AM. Dzierzbicka K, et al. Postepy Biochem. 2006;52(2):204-11. Postepy Biochem. 2006. PMID: 17078510 Review. Polish. - Bacterial ghosts as adjuvant particles.
Riedmann EM, Kyd JM, Cripps AW, Lubitz W. Riedmann EM, et al. Expert Rev Vaccines. 2007 Apr;6(2):241-53. doi: 10.1586/14760584.6.2.241. Expert Rev Vaccines. 2007. PMID: 17408373 Review. - Novel strategies using DNA for the induction of mucosal immunity.
McCluskie MJ, Davis HL. McCluskie MJ, et al. Crit Rev Immunol. 1999;19(4):303-29. Crit Rev Immunol. 1999. PMID: 10530431 Review. - Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P, Horsmans Y, Moris P, Van Mechelen M, Janssens M, Koutsoukos M, Van Belle P, Clement F, Hanon E, Wettendorff M, Garçon N, Leroux-Roels G. Vandepapelière P, et al. Vaccine. 2008 Mar 4;26(10):1375-86. doi: 10.1016/j.vaccine.2007.12.038. Epub 2008 Jan 14. Vaccine. 2008. PMID: 18272264 Clinical Trial. - Recent developments in adjuvants for vaccines against infectious diseases.
O'Hagan DT, MacKichan ML, Singh M. O'Hagan DT, et al. Biomol Eng. 2001 Oct 15;18(3):69-85. doi: 10.1016/s1389-0344(01)00101-0. Biomol Eng. 2001. PMID: 11566599 Review.
Cited by
- Development and Applications of PLGA Hydrogels for Sustained Delivery of Therapeutic Agents.
Visan AI, Negut I. Visan AI, et al. Gels. 2024 Jul 26;10(8):497. doi: 10.3390/gels10080497. Gels. 2024. PMID: 39195026 Free PMC article. Review. - Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants.
Scharton-Kersten T, Yu Jm, Vassell R, O'Hagan D, Alving CR, Glenn GM. Scharton-Kersten T, et al. Infect Immun. 2000 Sep;68(9):5306-13. doi: 10.1128/IAI.68.9.5306-5313.2000. Infect Immun. 2000. PMID: 10948159 Free PMC article. - Immunogenicity of a multi-component recombinant human acrosomal protein vaccine in female Macaca fascicularis.
Kurth BE, Digilio L, Snow P, Bush LA, Wolkowicz M, Shetty J, Mandal A, Hao Z, Reddi PP, Flickinger CJ, Herr JC. Kurth BE, et al. J Reprod Immunol. 2008 Apr;77(2):126-41. doi: 10.1016/j.jri.2007.06.001. Epub 2007 Jul 23. J Reprod Immunol. 2008. PMID: 17643494 Free PMC article. - Profiles of carbohydrate ligands associated with adsorbed proteins on self-assembled monolayers of defined chemistries.
Shankar SP, Chen II, Keselowsky BG, García AJ, Babensee JE. Shankar SP, et al. J Biomed Mater Res A. 2010 Mar 15;92(4):1329-42. doi: 10.1002/jbm.a.32457. J Biomed Mater Res A. 2010. PMID: 19353560 Free PMC article. - Lysine: Is it worth more?
Datta D, Bhinge A, Chandran V. Datta D, et al. Cytotechnology. 2001 Jul;36(1-3):3-32. doi: 10.1023/A:1014097121364. Cytotechnology. 2001. PMID: 19003311 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources